2022
DOI: 10.1016/j.bja.2022.03.030
|View full text |Cite
|
Sign up to set email alerts
|

Development and internal validation of a multivariable risk prediction model for severe rebound pain after foot and ankle surgery involving single-shot popliteal sciatic nerve block

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
1
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 35 publications
0
8
1
1
Order By: Relevance
“…Peripheral nerve block is an important part of regional anesthesia and has been widely used in kinds of surgeries, especially orthopedics. 2 , 4 , 24 One of the risk factors of rebound pain has been reported to be blocking the regions of relatively dense nerve distribution, such as brachial plexus and popliteal space. 4 , 6 We suggest that future studies of rebound pain would better base on these findings.…”
Section: Discussionmentioning
confidence: 99%
“…Peripheral nerve block is an important part of regional anesthesia and has been widely used in kinds of surgeries, especially orthopedics. 2 , 4 , 24 One of the risk factors of rebound pain has been reported to be blocking the regions of relatively dense nerve distribution, such as brachial plexus and popliteal space. 4 , 6 We suggest that future studies of rebound pain would better base on these findings.…”
Section: Discussionmentioning
confidence: 99%
“…Bedenkt man, dass die Zeit, in der dieses Phänomen aufzutreten scheint, regelhaft nicht in anästhesiologischer Verantwortung ist [3], lässt sich nachvollziehen, dass Autoren aus USA eher organisatorische Lücken als ein biologisches Phänomen vermuten [4]. So ist es auch nicht wirklich verwunderlich, wenn Regressionsmodelle, in denen organisatorische Defizite unberücksichtigt bleiben [5], nicht in der Lage sind, das Auftreten vorherzusagen.…”
Section: Kommentarunclassified
“…The sample size for the study was calculated using SAS version 9.1. According to the published literature, 14 the incidence of rebound pain is about 50%. We aimed to reduce rebound pain by 25% in group IV compared to group C. We calculated that 58 patients per group were needed (power = 80%, α = 0.05), but to allow for the incidence of patient withdrawals, we planned for 65 patients per group.…”
Section: Study Design and Participantsmentioning
confidence: 99%